Nyxoah (NASDAQ:NYXH – Get Free Report) is anticipated to announce its earnings results before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings of ($0.48) per share for the quarter.
Nyxoah Trading Up 0.1 %
NASDAQ NYXH opened at $10.36 on Tuesday. The firm’s 50 day moving average price is $9.77 and its two-hundred day moving average price is $9.01. The stock has a market cap of $352.86 million, a price-to-earnings ratio of -5.54 and a beta of 1.41. Nyxoah has a twelve month low of $6.76 and a twelve month high of $20.00. The company has a debt-to-equity ratio of 0.21, a quick ratio of 4.95 and a current ratio of 5.28.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on NYXH. HC Wainwright reissued a “buy” rating and set a $17.00 target price on shares of Nyxoah in a research note on Friday, December 13th. Cantor Fitzgerald reissued an “overweight” rating and set a $16.00 target price on shares of Nyxoah in a research note on Tuesday, November 5th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Nyxoah presently has an average rating of “Buy” and an average price target of $17.00.
Nyxoah Company Profile
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.
Recommended Stories
- Five stocks we like better than Nyxoah
- Where to Find Earnings Call Transcripts
- Rivian’s Rough Patch: Is the Dip a Doorway to Long-Term Gains?
- 3 Best Fintech Stocks for a Portfolio Boost
- Institutions Signal Opportunty to Buy High-Yield Kraft-Heinz
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Explosive Tech Stocks Breaking Out Right Now
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.